Denna lista är en analys baserad på senaste marknadshändelser. Det är ingen investeringsrekommendation.
Om
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. it provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology and its intraoperative neuromonitoring services and support; and specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone. The company also offers reline fixation system that facilitates the preservation and restoration of patient alignment; integrated global alignment platform consisting of Bendini spinal rod bending system that assists with manual rod manipulation for spinal fixation; Lessray that is an image enhancement platform designed to reduce radiation exposure in the operating room, as well as Pulse, which integrates multiple enabling technologies to enhance workflow, reduce variability, and increase the reproducibility of surgical outcomes; and various biologics that are used to aid in the spinal fusion or bone healing process. In addition, it provides MAGEC, a spinal bracing and distraction system, Precice limb lengthening system, and various other products for treating specialized orthopedic procedures; onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries; and cervical artificial disc technology for cervical total disc replacement procedures. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
Show more...
VD
Mr. J. Christopher Barry
Anställda
2700
Land
USA
ISIN
US6707041058
WKN
000A0CAYR
Noteringar
0 Comments
Dela dina tankar
FAQ
Vad är Nuvasives aktiekurs idag?▼
Det aktuella priset för NK8.F är €36.8 EUR — det har ökat med +0% under de senaste 24 timmarna. Följ Nuvasive-aktiens utveckling närmare i diagrammet.
Vad är Nuvasives aktiesymbol?▼
Beroende på börsen kan aktiesymbolen variera. Till exempel handlas Nuvasive-aktien på börsen under symbolen NK8.F.
Vad är Nuvasives börsvärde?▼
Idag har Nuvasive ett börsvärde på 1.92B
Vad var Nuvasives intäkter förra året?▼
Nuvasives intäkter för det senaste året uppgår till 1.14B EUR.
Vad var Nuvasives nettoresultat förra året?▼
NK8.Fs nettovinst för det senaste året är 36.91M EUR.
Hur många anställda har Nuvasive?▼
Från och med april 29, 2026 har företaget 2,700 anställda.